dutchfella - Do you really believe that RVX is "priced for perfection" at $1.30?

This BTD that apabetalone received a couple of weeks ago has gone completely unnoticed by the market. IMO "priced for perfection" would be between $31 and $52 per share. If you work that backwards it comes to a US$ M/C of $6 to $10 billion. 

IMO the minute this BTD was announced, RVX morphed from an extremely risky baby Cdn biotech into one of the best value stocks available in North America.

Many of the current shareholders and people who have listened to the RVX story at any time in the past and have only experienced disappointment have completely missed this. The company is not the one that said to the world "listen up here and pay attention" it is the FDA, one of the bodies that have the ability to allow this drug to eventually be available to the mass markets. The game totally changed the minute that BTD status was granted. Anyone holding baggage from the past may want to reconsider this importance.

All IMO, dyodd

tada